Designation: Professor
Department: Chemistry
University: Texas A&M University
Country: United States
Dr. Apu is a professor in the Department of Chemistry at Tamuk . He provided leadership and strategic direction for the global R&D (consisting of more than 700 Ph.D. Chemists and Engineers) and serve on senior R&D staff that is responsible for ensuring effective and innovative product development. Dr. Apurba has over twenty years of experience in Pharmaceutical industry in the areas of drug delivery and drug development. He is a Scientific Process Advisor for several pharmaceutical companies. He is a Member of the National Academies’ Chemical Sciences Roundtable (CSR), National Academies Committee on Promoting Safe and secure chemical Management in Developing countries; American Chemical Society Green Chemistry Institute (ACS GCI) Pharmaceutical Roundtable and Panel of Drug Evaluators for Current Drugs (CD). Responsible for the evaluation of drugs, which are being launched worldwide under FDA guidelines
Dr. Apu’s research interests include Pharmaceutical Process Research and Development and Environmentally Benign Processes in Organic Synthesis.
Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to
Send Information
Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.
We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.
Do you have an idea or suggestion that can influence the Open Access community? Send an email to: support@boffinaccess.org
Copyright © 2020 Boffin Access Limited.
